Omeros CorpNASDAQ:OMER
- LAST PRICE6.7500
- TODAY'S CHANGE (%)-0.2000 (-2.8777%)
- Bid / Lots6.7500/ 39
- Ask / Lots6.7800/ 1
- Open / Previous Close7.0000 / 6.9500
- Day Range
- 52 Week Range
- Volume1,941,127
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | OMER |
|---|---|---|
| 09:32 ET | 66693 | 6.93 |
| 09:33 ET | 69743 | 6.7776 |
| 09:35 ET | 30155 | 6.6828 |
| 09:37 ET | 50700 | 6.615 |
| 09:39 ET | 34981 | 6.6704 |
| 09:42 ET | 15543 | 6.77 |
| 09:44 ET | 15189 | 6.73 |
| 09:46 ET | 15758 | 6.86 |
| 09:48 ET | 4863 | 6.7207 |
| 09:50 ET | 4223 | 6.7324 |
| 09:51 ET | 4931 | 6.865 |
| 09:53 ET | 15060 | 6.88 |
| 09:55 ET | 18512 | 6.8508 |
| 09:57 ET | 10074 | 6.93 |
| 10:00 ET | 4836 | 6.91 |
| 10:02 ET | 3420 | 6.925 |
| 10:04 ET | 8181 | 6.951 |
| 10:06 ET | 4725 | 6.95 |
| 10:08 ET | 12103 | 6.88 |
| 10:09 ET | 7908 | 6.8609 |
| 10:11 ET | 39832 | 6.7765 |
| 10:13 ET | 2570 | 6.76 |
| 10:15 ET | 9461 | 6.788 |
| 10:18 ET | 2699 | 6.825 |
| 10:20 ET | 1362 | 6.78 |
| 10:22 ET | 5909 | 6.73 |
| 10:24 ET | 6190 | 6.8 |
| 10:26 ET | 100 | 6.8 |
| 10:27 ET | 5248 | 6.77 |
| 10:29 ET | 28190 | 6.73 |
| 10:31 ET | 5509 | 6.6402 |
| 10:33 ET | 14073 | 6.75 |
| 10:36 ET | 1730 | 6.74 |
| 10:38 ET | 2800 | 6.75 |
| 10:40 ET | 2059 | 6.72 |
| 10:42 ET | 3130 | 6.725 |
| 10:44 ET | 13050 | 6.7086 |
| 10:45 ET | 75300 | 6.68 |
| 10:47 ET | 1500 | 6.7 |
| 10:49 ET | 47649 | 6.695 |
| 10:51 ET | 34396 | 6.705 |
| 10:54 ET | 12055 | 6.705 |
| 10:56 ET | 2192 | 6.68 |
| 10:58 ET | 19711 | 6.63 |
| 11:00 ET | 2056 | 6.67 |
| 11:02 ET | 11806 | 6.625 |
| 11:03 ET | 11693 | 6.68 |
| 11:05 ET | 7445 | 6.7 |
| 11:07 ET | 900 | 6.7 |
| 11:09 ET | 330 | 6.74 |
| 11:12 ET | 3300 | 6.73 |
| 11:14 ET | 12476 | 6.84 |
| 11:16 ET | 7466 | 6.85 |
| 11:18 ET | 15954 | 6.845 |
| 11:20 ET | 1290 | 6.86 |
| 11:21 ET | 5278 | 6.835 |
| 11:23 ET | 11700 | 6.835 |
| 11:25 ET | 700 | 6.85 |
| 11:27 ET | 769 | 6.85 |
| 11:30 ET | 200 | 6.88 |
| 11:32 ET | 100 | 6.88 |
| 11:34 ET | 2579 | 6.86 |
| 11:36 ET | 300 | 6.8475 |
| 11:38 ET | 1700 | 6.855 |
| 11:39 ET | 20896 | 6.87 |
| 11:41 ET | 400 | 6.85 |
| 11:43 ET | 11700 | 6.865 |
| 11:48 ET | 8481 | 6.895 |
| 11:50 ET | 3388 | 6.92 |
| 11:52 ET | 1950 | 6.92 |
| 11:54 ET | 9645 | 6.905 |
| 11:56 ET | 3870 | 6.92 |
| 11:57 ET | 7116 | 6.93 |
| 11:59 ET | 11388 | 6.9415 |
| 12:01 ET | 16161 | 6.99 |
| 12:03 ET | 24966 | 7.0898 |
| 12:06 ET | 17204 | 7.06 |
| 12:08 ET | 5900 | 7.0436 |
| 12:10 ET | 13871 | 7.06 |
| 12:12 ET | 5020 | 7.07 |
| 12:14 ET | 1827 | 7.08 |
| 12:15 ET | 14431 | 7.0397 |
| 12:17 ET | 32164 | 6.94 |
| 12:19 ET | 16722 | 7.025 |
| 12:21 ET | 527 | 7.01 |
| 12:24 ET | 6532 | 7.0491 |
| 12:26 ET | 12115 | 7.06 |
| 12:28 ET | 17618 | 7.1 |
| 12:30 ET | 8900 | 7.1 |
| 12:32 ET | 1336 | 7.12 |
| 12:33 ET | 4538 | 7.11 |
| 12:35 ET | 5795 | 7.06 |
| 12:37 ET | 900 | 7.05 |
| 12:39 ET | 4779 | 7.01 |
| 12:42 ET | 2100 | 6.97 |
| 12:44 ET | 7715 | 6.93 |
| 12:46 ET | 1100 | 6.96 |
| 12:48 ET | 200 | 7.005 |
| 12:50 ET | 1400 | 7.005 |
| 12:51 ET | 100 | 6.96 |
| 12:53 ET | 5018 | 7 |
| 12:55 ET | 400 | 6.98 |
| 12:57 ET | 290 | 6.96 |
| 01:00 ET | 3296 | 6.995 |
| 01:02 ET | 1100 | 6.985 |
| 01:04 ET | 1195 | 6.96 |
| 01:06 ET | 1211 | 6.95 |
| 01:08 ET | 7954 | 6.935 |
| 01:09 ET | 13011 | 6.91 |
| 01:11 ET | 11300 | 6.9117 |
| 01:15 ET | 6092 | 6.88 |
| 01:18 ET | 9710 | 6.88 |
| 01:20 ET | 4956 | 6.84 |
| 01:22 ET | 7990 | 6.88 |
| 01:24 ET | 14848 | 6.85 |
| 01:26 ET | 2890 | 6.85 |
| 01:27 ET | 7942 | 6.82 |
| 01:29 ET | 400 | 6.815 |
| 01:31 ET | 621 | 6.815 |
| 01:33 ET | 2676 | 6.83 |
| 01:36 ET | 3355 | 6.88 |
| 01:38 ET | 6203 | 6.91 |
| 01:40 ET | 3800 | 6.86 |
| 01:42 ET | 2539 | 6.835 |
| 01:44 ET | 5600 | 6.85 |
| 01:45 ET | 1373 | 6.83 |
| 01:51 ET | 200 | 6.82 |
| 01:54 ET | 2378 | 6.805 |
| 01:56 ET | 3944 | 6.8 |
| 01:58 ET | 700 | 6.79 |
| 02:00 ET | 200 | 6.79 |
| 02:02 ET | 2017 | 6.77 |
| 02:03 ET | 1993 | 6.81 |
| 02:05 ET | 22284 | 6.745 |
| 02:09 ET | 330 | 6.7384 |
| 02:12 ET | 450 | 6.74 |
| 02:14 ET | 700 | 6.79 |
| 02:18 ET | 800 | 6.75 |
| 02:20 ET | 794 | 6.72 |
| 02:21 ET | 833 | 6.72 |
| 02:23 ET | 525 | 6.72 |
| 02:25 ET | 547 | 6.715 |
| 02:27 ET | 4812 | 6.66 |
| 02:30 ET | 500 | 6.64 |
| 02:32 ET | 11074 | 6.65 |
| 02:34 ET | 8415 | 6.62 |
| 02:36 ET | 4200 | 6.65 |
| 02:38 ET | 200 | 6.6599 |
| 02:39 ET | 200 | 6.64 |
| 02:41 ET | 2275 | 6.65 |
| 02:43 ET | 850 | 6.67 |
| 03:15 ET | 1847 | 6.655 |
| 03:17 ET | 1300 | 6.65 |
| 03:19 ET | 2300 | 6.635 |
| 03:21 ET | 2710 | 6.67 |
| 03:24 ET | 3697 | 6.67 |
| 03:26 ET | 2760 | 6.645 |
| 03:28 ET | 2350 | 6.65 |
| 03:30 ET | 2777 | 6.665 |
| 03:32 ET | 300 | 6.65 |
| 03:33 ET | 8700 | 6.75 |
| 03:35 ET | 3948 | 6.75 |
| 03:37 ET | 21114 | 6.76 |
| 03:39 ET | 10968 | 6.745 |
| 03:42 ET | 1110 | 6.745 |
| 03:44 ET | 8415 | 6.75 |
| 03:46 ET | 8434 | 6.76 |
| 03:48 ET | 10349 | 6.8 |
| 03:50 ET | 4527 | 6.76 |
| 03:51 ET | 11383 | 6.75 |
| 03:53 ET | 14520 | 6.755 |
| 03:55 ET | 18556 | 6.755 |
| 03:57 ET | 16295 | 6.755 |
| 04:00 ET | 115911 | 6.75 |
Yesterday
DJ Omeros Shares Hit 52-Week High on Plan to Resubmit Narsoplimab Application, from 1:33PM ET on Thursday Nov 14, 2024 by Dow Jones
1:33PM ET on Thursday Nov 14, 2024 by Dow JonesDJ Omeros Up Over 49%, On Pace for Largest Percent Increase Since February 2023 -- Data Talk, from 11:25AM ET on Thursday Nov 14, 2024 by Dow Jones
11:25AM ET on Thursday Nov 14, 2024 by Dow JonesDJ Omeros Initiated at Buy by Rodman & Renshaw, from 7:04AM ET on Thursday Nov 14, 2024 by Dow Jones
7:04AM ET on Thursday Nov 14, 2024 by Dow Jones
Nov 13, 2024
Omeros Corporation Reports Third Quarter 2024 Financial Results, from 4:02PM ET on Wednesday Nov 13, 2024 by Dow Jones
4:02PM ET on Wednesday Nov 13, 2024 by Dow Jones*DJ Omeros 3Q Loss/Shr 56c >OMER, from 4:02PM ET on Wednesday Nov 13, 2024 by Dow Jones
4:02PM ET on Wednesday Nov 13, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Omeros Corp | 402.7M | -2.0x | --- |
Lexicon Pharmaceuticals Inc | 383.2M | -1.3x | --- |
Prime Medicine Inc | 431.5M | -1.6x | --- |
Northwest Biotherapeutics Inc | 376.4M | -4.4x | --- |
Q32 Bio Inc | 434.0M | -4.4x | --- |
enGene Holdings Inc | 350.6M | -1.6x | --- |
Company Information
Omeros Corporation is a biopharmaceutical company. The Company is focused on discovering, developing and commercializing small-molecule and protein therapeutics for large-market and orphan indications targeting immunologic disorders, including complement-mediated diseases, cancers, and addictive and compulsive disorders. Its lead MASP-2 inhibitor, narsoplimab, targets the lectin pathway of complement and is the subject of a biologics license application pending before FDA for the treatment of hematopoietic stem cell transplant-associated thrombotic microangiopathy. Its long-acting MASP-2 inhibitor, OMS1029, is in a phase I multi-ascending-dose clinical trial. OMS906, its inhibitor of MASP-3, the key activator of the alternative pathway of complement, is advancing in clinical programs for paroxysmal nocturnal hemoglobinuria and complement 3 glomerulopathy. The Company’s lead phosphodiesterase 7 inhibitor OMS527 is in clinical development for the treatment of cocaine use disorders.
Contact Information
- Headquarters
- 201 Elliott Avenue WestSEATTLE, WA, United States 98119
- Phone
- 206-676-5000
- Fax
- 206-676-5005
Executives
- Chairman of the Board, President, Chief Executive Officer
- Gregory Demopulos
- Chief Accounting Officer, Vice President - Finance, Treasurer
- David Borges
- Vice President - Science, Chief Scientific Officer
- George Gaitanaris
- Vice President, General Counsel, Secretary
- Peter Cancelmo
- Vice President - Human Resources
- Peter Williams
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $402.7M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 57.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.62 |
EPS | $-3.32 |
Book Value | $-0.41 |
P/E Ratio | -2.0x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
